Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Maj 2022

Genmab — Maj 2022

Planlagt Fastgjort Låst Flyttet Genmab
1.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • SolsenS Offline
    SolsenS Offline
    Solsen
    wrote on sidst redigeret af
    #1233

    https://endpts.com/roches-cd20xcd3-doesnt-beat-genmab-at-orr-but-sets-bar-for-cr-data-on-lymphoma-drug/ Roche arbejder for det.

    1 Reply Last reply
    0
    • BulderB Offline
      BulderB Offline
      Bulder
      wrote on sidst redigeret af
      #1234

      Ja, så ved vi, hvad vi skal kigge efter i næste uge, hvis epco når med som lba på eha: 32% hhv 37% CR med hhv uden forudgående car-t. Vi håber det bedste.

      1 Reply Last reply
      0
      • BulderB Offline
        BulderB Offline
        Bulder
        wrote on sidst redigeret af
        #1235

        Gns CR var for glofi 35,2%. Jeg tror epco kommer til at ligge deromkring. Men en behagelig overraskelse vil ikke være af vejen.

        1 Reply Last reply
        0
        • BulderB Offline
          BulderB Offline
          Bulder
          wrote on sidst redigeret af
          #1236

          Winkel på CC: And I can assure you that a lot of data you haven't seen yet, this is a very heavily pretreated population, and we have not told you anything yet on complete responses, duration, etc., of dose responses and other color in the data set. So we believe the data set is very encouraging…

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #1237

            Kan måske tolkes som at vi ligger på den rigtige side af 35,2%.

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #1238

              Vi kan muligvis ende der, at epco har lidt lavere CR, men en mere syg population.

              1 Reply Last reply
              0
              • BulderB Offline
                BulderB Offline
                Bulder
                wrote on sidst redigeret af
                #1239

                I hvert fald har epco ingen grad 4 CRS, i modsætning til glofi.

                1 Reply Last reply
                0
                • SolsenS Offline
                  SolsenS Offline
                  Solsen
                  wrote on sidst redigeret af
                  #1240

                  CarT data i MM er voldsomt gode. Men der skal større forsøg og længere opfølgning til https://twitter.com/jacobplieth/status/1529930376432349184?s=21&t=z8qiRvo9t1Avj0dljk2o9A

                  1 Reply Last reply
                  0
                  • BulderB Offline
                    BulderB Offline
                    Bulder
                    wrote on sidst redigeret af
                    #1241

                    Dara plus teclistamab kombien var da lige så god, så vidt jeg husker.

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #1242

                      Just a moment...

                      favicon

                      (www.onclive.com)

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #1243

                        Men det forspring har vi måske indhentet på torsdag.

                        1 Reply Last reply
                        0
                        • SolsenS Offline
                          SolsenS Offline
                          Solsen
                          wrote on sidst redigeret af
                          #1244

                          Jeg tvivlet også stadig på CarT’s konkurrenceevne. Og CD19 er et tvivlsomt target mht SAE. Så rigtigt bulder så er tec+dara rigtig spændende.

                          1 Reply Last reply
                          0
                          • J Offline
                            J Offline
                            JKY_VH
                            wrote on sidst redigeret af
                            #1245

                            men muligheden er der, så JnJ har al mulig interesse i at gå med i udviklingen af CD38

                            1 Reply Last reply
                            0
                            • B Offline
                              B Offline
                              bibob
                              wrote on sidst redigeret af
                              #1246

                              Også en god nyhed fra ASCO fra JnJ. https://www.fiercebiotech.com/biotech/asco-jjs-multiple-myeloma-toolkit-expands-bispecifics-data?utm_source=email&utm_medium=email&utm_campaign=LS-NL-FierceBiotech&oly_enc_id=6900G6464778A3A

                              1 Reply Last reply
                              0
                              • B Offline
                                B Offline
                                bibob
                                wrote on sidst redigeret af
                                #1247

                                Just a moment...

                                favicon

                                (www.fiercebiotech.com)

                                1 Reply Last reply
                                0
                                • B Offline
                                  B Offline
                                  bibob
                                  wrote on sidst redigeret af
                                  #1248

                                  Will J&J buy Boston Scientific. ?? https://www.massdevice.com/will-johnson-johnson-buy-boston-scientific/

                                  1 Reply Last reply
                                  0
                                  • BulderB Offline
                                    BulderB Offline
                                    Bulder
                                    wrote on sidst redigeret af
                                    #1249

                                    Carvykti: “We’ve taken a different point of view and said […] let’s treat those patients who are treatment-naïve,” Widgust said. “I think we’re saying let’s go right to the newly diagnosed setting.”

                                    1 Reply Last reply
                                    0
                                    • BulderB Offline
                                      BulderB Offline
                                      Bulder
                                      wrote on sidst redigeret af
                                      #1250

                                      Just a moment...

                                      favicon

                                      (www.fiercepharma.com)

                                      1 Reply Last reply
                                      0
                                      • B Offline
                                        B Offline
                                        bibob
                                        wrote on sidst redigeret af
                                        #1251

                                        Just a moment...

                                        favicon

                                        (www.fiercepharma.com)

                                        1 Reply Last reply
                                        0
                                        • J Offline
                                          J Offline
                                          JKY_VH
                                          wrote on sidst redigeret af
                                          #1252

                                          Så lad os deltage i "Langers" fest https://ugebrev.dk/flashnews/langers-skarpe-kaempe-aktiefest-forude-oeus-investeringsfond-oeger-i-tech-og-biotech/?utm_source=Dagens+nyheder&utm_campaign=225cda3853-Dagens+Nyheder+-+Investering+Aften&utm_medium=email&utm_term=0_854578a5a7-225cda3853-108502749&mc_cid=225cda3853&mc_eid=398e30fe9c

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper